Fierce Healthcare August 1, 2024
Heather Landi

R1 RCM, a company that provides revenue cycle and billing services to hospitals, will be acquired for $8.9 billion and taken private.

Investment funds tied to TowerBrook Capital Partners and Clayton, Dubilier & Rice will pay $14.30 per share in cash for the company, the health tech company said in a press release Thursday.

TowerBrook already has a 36% stake in the company, according to the press release.

In late February, private equity firm New Mountain Capital, R1’s largest shareholder, made a buyout proposal that valued the company at nearly $6 billion.

TowerBrook and CD&R’s proposed purchase price is a 29% premium to the company’s closing price before New Mountain’s interest became public, the company said in a press release.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, RCM (Revenue Cycle Mgmt), Technology, Trends
Aspirion lands 7th acquisition in 6 years
Revenue Cycle Risk Takers
Revenue Cycle AI Is Costly and Cumbersome. Here's Why Leaders Are Still Buying In.
Medical Tourism and Global Private Healthcare Drive Revenue Cycle Innovation: Black Book Report
4 Cornerstones for Successful AI Implementation in Hospital Revenue Cycle Management in 2025

Share This Article